The world’s first study on an antibody treatment against COVID-19 has roots right here in Indiana. Indianapolis-based Eli Lilly has started an early-stage human trial to test its potential treatment for the virus. Lilly Chairman and CEO Dave Ricks discusses the study and when it could become available.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}